Koers ZIVO Bioscience, Inc. Other OTC
Aandelen
ZIVO
US98978N1019
Voedselverwerking
Omzet 2024 * | 545K 506K | Omzet 2025 * | 1,51 mln. 1,4 mln. | Marktkapitalisatie | 22,4 mln. 20,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,42 mln. | Nettowinst (verlies) 2025 * | -8 mln. -7,42 mln. | EV/omzet 2024 * | 41,1 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 14,9 x |
K/w-verhouding 2024 * |
-2,55
x | K/w-verhouding 2025 * |
-3,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 59,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 19-07-13 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 01-01-21 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 17-09-14 | |
Director/Board Member | 58 | 28-08-13 | |
John Payne
CEO | Chief Executive Officer | 76 | 19-07-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,45% | 8,39 mld. | |
+3,59% | 7,58 mld. | |
+15,12% | 6,72 mld. | |
-5,87% | 3,73 mld. | |
+5,27% | 1,44 mld. | |
-30,67% | 1,03 mld. | |
+21,35% | 1,03 mld. | |
-13,58% | 858 mln. | |
-19,00% | 785 mln. |